Abstract
The drug delivery industry has in recent years become a key partner for
pharmaceutical companies in their efforts to maximize the patent lives of
successful products. Drug delivery companies not only stand to benefit from
patent expiry by providing their reformulation services to pharmaceutical
companies, but also by producing their own versions of branded products with
improved delivery mechanisms. Thus, post-patent expiry sales can be switched
from the ethical manufacturer to the drug delivery sector.
The Global Drug Delivery Market: Research Trends and Market Outlook is an
up-to-date guide that assesses the current state of the drug delivery industry
and its application to both the pharmaceutical and biotech industries. While
the sector is still dominated by oral technologies, drug delivery systems have
expanded to include more novel devices such as needleless injectables,
PEGylation platforms and microelectromechanical devices. These technological
advances extend the duration of a drug's action, increase delivery to target
sites, reduce delivery to unwanted sites, and maximize drug absorption.
The expanding market for biotechnology and gene-based products, which by their
very nature are difficult to administer, represents an emerging opportunity
for drug delivery technologies. These technologies are first expected to come
to market as reformulations of existing macromolecular therapies, such as
insulin. This report analyzes the markets for oral, inhalable, injectable,
transmucosal, transdermal and niche drug delivery technologies as they apply
to both biotech and traditional pharmacological compounds.
Key Features of This Report:
- A thorough overview of both marketed and emerging drug delivery
technologies set to impact the global pharmaceutical market
- Analysis of the opportunities and threats to the global drug delivery
industry
- Profiles of drug delivery companies along with key financial figures and
technology/product portfolios
- Market analysis and outlook for the leading drug delivery technologies,
including oral, injectable, inhalable, transdermal, transmucosal and niche
technologies
- Profiles of key emerging drug delivery technologies and profiles of
leading companies, by type of technology
| 
View Cart
